Akebia Therapeutics, Inc. financial data

Symbol
AKBA on Nasdaq
Location
245 First Street, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 183 % +42.8%
Quick Ratio 20.5 % -13.2%
Debt-to-equity -2.47K % -207%
Return On Equity 319 % +158%
Return On Assets -13.5 % +23.2%
Operating Margin 0.39 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 265M shares +26.1%
Common Stock, Shares, Outstanding 263M shares +25.3%
Entity Public Float 211M USD +24.3%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 263M shares +25.2%
Weighted Average Number of Shares Outstanding, Diluted 271M shares +29.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 204M USD +16.8%
Cost of Revenue 52.1M USD -20.3%
Research and Development Expense 41M USD +1.15%
Operating Income (Loss) 792K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -36.5M USD +9.79%
Net Income (Loss) Attributable to Parent -36.5M USD +9.79%
Earnings Per Share, Basic 0 USD/shares +15%
Earnings Per Share, Diluted 0 USD/shares +15%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 137M USD +248%
Accounts Receivable, after Allowance for Credit Loss, Current 72.8M USD +145%
Inventory, Net 16.7M USD -30%
Other Assets, Current 7.83M USD +6.86%
Assets, Current 235M USD +109%
Property, Plant and Equipment, Net 1.71M USD -40.8%
Operating Lease, Right-of-Use Asset 5.99M USD -42.2%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 59M USD 0%
Other Assets, Noncurrent 44.2M USD +149%
Assets 346M USD +56.9%
Accounts Payable, Current 11.6M USD +14.3%
Employee-related Liabilities, Current 6.75M USD +6.05%
Accrued Liabilities, Current 91.6M USD +70%
Contract with Customer, Liability, Current 5.53M USD -87.2%
Liabilities, Current 119M USD +10.6%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 671K USD -89.3%
Other Liabilities, Noncurrent 5.36M USD -18.3%
Liabilities 316M USD +24.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 6K USD 0%
Retained Earnings (Accumulated Deficit) -1.67B USD -2.23%
Stockholders' Equity Attributable to Parent 29.2M USD
Liabilities and Equity 346M USD +56.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.6M USD +30.1%
Net Cash Provided by (Used in) Financing Activities 74.9M USD +306%
Net Cash Provided by (Used in) Investing Activities 154K USD
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 263M shares +25.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 61.5M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 139M USD +238%
Deferred Tax Assets, Valuation Allowance 388M USD +6.15%
Deferred Tax Assets, Gross 391M USD +3.77%
Operating Lease, Liability 6.3M USD -45.1%
Depreciation 314K USD -13.7%
Payments to Acquire Property, Plant, and Equipment 18K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -36.5M USD +9.79%
Lessee, Operating Lease, Liability, to be Paid 6.53M USD -47%
Operating Lease, Liability, Current 5.63M USD +8.69%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.61M USD -37.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.61M USD -37.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 227K USD -72.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.61M USD -56.4%
Deferred Tax Assets, Operating Loss Carryforwards 292M USD +0.96%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.57M USD -60.9%
Operating Lease, Payments 5.9M USD +5.36%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 27M USD -25%
Deferred Tax Assets, Net of Valuation Allowance 3.38M USD -71%
Share-based Payment Arrangement, Expense 8.21M USD +5.61%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%